Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 29 07 2018
accepted: 08 01 2019
revised: 21 12 2018
pubmed: 17 1 2019
medline: 15 6 2019
entrez: 17 1 2019
Statut: ppublish

Résumé

Little is known about the influence of multiple sclerosis (MS) diagnosis on parenthood attitude in people with MS (pwMS). To investigate the impact of diagnosis, clinical features and external disease-related influences on parenthood decision-making in Italian pwMS. A web-based survey was posted on SMsocialnetwork.com to investigate clinical status, parenthood desire, influences on family planning, pregnancy outcomes, abortions and adoptions of pwMS. 33/395 respondents never wanted to become parent because of MS ("anti-parenthood after diagnosis"). 362 declared to be in favor of parenthood. 51% pwMS having a child by the survey time had already received the MS diagnosis at first childbirth. The frequency of a second child in pwMS after diagnosis was 38% compared to 67% in people without yet MS diagnosis. 16% of pwMS were discouraged to become parent after diagnosis, mainly by medical personnel. In 71% of respondents, diagnosis did not delay the decision to become parent and only 39% were counseled by treating physician to plan pregnancy. Patients' distribution according to the clinical phenotype (exclusively relapsing vs exclusively progressive) showed a higher proportion of progressive patients in the "anti-parenthood after diagnosis" subgroup. MS diagnosis impacted dramatically on the life project of 7% of pwMS that decided not to have children because of the disease and in pro-parenthood pwMS impacted especially on having the second child. Only a minority was counseled to plan pregnancy. A worse disease course driving to a progressive phenotype at survey time might have negatively impacted on parenthood desire.

Sections du résumé

BACKGROUND BACKGROUND
Little is known about the influence of multiple sclerosis (MS) diagnosis on parenthood attitude in people with MS (pwMS).
OBJECTIVE OBJECTIVE
To investigate the impact of diagnosis, clinical features and external disease-related influences on parenthood decision-making in Italian pwMS.
METHODS METHODS
A web-based survey was posted on SMsocialnetwork.com to investigate clinical status, parenthood desire, influences on family planning, pregnancy outcomes, abortions and adoptions of pwMS.
RESULTS RESULTS
33/395 respondents never wanted to become parent because of MS ("anti-parenthood after diagnosis"). 362 declared to be in favor of parenthood. 51% pwMS having a child by the survey time had already received the MS diagnosis at first childbirth. The frequency of a second child in pwMS after diagnosis was 38% compared to 67% in people without yet MS diagnosis. 16% of pwMS were discouraged to become parent after diagnosis, mainly by medical personnel. In 71% of respondents, diagnosis did not delay the decision to become parent and only 39% were counseled by treating physician to plan pregnancy. Patients' distribution according to the clinical phenotype (exclusively relapsing vs exclusively progressive) showed a higher proportion of progressive patients in the "anti-parenthood after diagnosis" subgroup.
CONCLUSION CONCLUSIONS
MS diagnosis impacted dramatically on the life project of 7% of pwMS that decided not to have children because of the disease and in pro-parenthood pwMS impacted especially on having the second child. Only a minority was counseled to plan pregnancy. A worse disease course driving to a progressive phenotype at survey time might have negatively impacted on parenthood desire.

Identifiants

pubmed: 30649617
doi: 10.1007/s00415-019-09193-4
pii: 10.1007/s00415-019-09193-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

707-716

Références

EPMA J. 2012 Jun 22;3(1):9
pubmed: 22738272
Mult Scler Relat Disord. 2018 Aug;24:129-134
pubmed: 30005355
Clin Psychol Rev. 2009 Mar;29(2):141-53
pubmed: 19167801
Mult Scler Relat Disord. 2017 Apr;13:28-32
pubmed: 28427697
Eur J Paediatr Neurol. 2016 Jan;20(1):158-63
pubmed: 26387071
Rev Neurol. 2014 Dec 16;59(12):537-42
pubmed: 25501451
Obstet Gynecol. 2014 Dec;124(6):1157-68
pubmed: 25415167
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
BMC Res Notes. 2010 Apr 03;3:91
pubmed: 20361873
Neurol Sci. 2017 Aug;38(8):1453-1459
pubmed: 28536948
Psychol Health Med. 2015;20(6):635-45
pubmed: 25588098
Qual Life Res. 2017 Mar;26(3):727-736
pubmed: 27928696
Interact J Med Res. 2017 Jul 14;6(2):e10
pubmed: 28710056
CMAJ. 2014 Aug 5;186(11):833-40
pubmed: 24756629
Lancet. 2002 Apr 6;359(9313):1221-31
pubmed: 11955556
Springerplus. 2013 May 14;2(1):222
pubmed: 23853744
Ther Adv Neurol Disord. 2016 May;9(3):198-210
pubmed: 27134675
CNS Drugs. 2015 Mar;29(3):207-20
pubmed: 25773609
Eur Neurol. 2014;72 Suppl 1:39-42
pubmed: 25278125
J Neurosci Nurs. 2002 Jun;34(3):145-57
pubmed: 12080870
Mult Scler. 2013 Mar;19(3):351-8
pubmed: 22760102
Acta Neurol Scand. 2003 Dec;108(6):389-95
pubmed: 14616290
Acta Neurol Scand. 2016 Dec;134(6):458-466
pubmed: 27219913
Mult Scler. 2017 Nov;23(13):1762-1771
pubmed: 27903935

Auteurs

L Lavorgna (L)

First Division of Neurology, University of Campania Luigi Vanvitelli, Piazza Miraglia, 2, 80138, Naples, Italy. luigi.lavorgna@policliniconapoli.it.

S Esposito (S)

First Division of Neurology, University of Campania Luigi Vanvitelli, Piazza Miraglia, 2, 80138, Naples, Italy.
Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

R Lanzillo (R)

Department of Neurosciences, Reproductive Sciences and Odontostomatology, University Federico II, Naples, Italy.

M Sparaco (M)

First Division of Neurology, University of Campania Luigi Vanvitelli, Piazza Miraglia, 2, 80138, Naples, Italy.

D Ippolito (D)

First Division of Neurology, University of Campania Luigi Vanvitelli, Piazza Miraglia, 2, 80138, Naples, Italy.

E Cocco (E)

Department of Medical Sciences and Public Health, Multiple Sclerosis Centre, Binaghi Hospital, University of Cagliari, Cagliari, Italy.

G Fenu (G)

Department of Medical Sciences and Public Health, Multiple Sclerosis Centre, Binaghi Hospital, University of Cagliari, Cagliari, Italy.

G Borriello (G)

Department of Neurology and Psychiatry, S. Andrea MS Center, Sapienza University, Rome, Italy.

S De Mercanti (S)

Clinical and Biological Sciences Department, University of Torino, Turin, Italy.

J Frau (J)

Department of Medical Sciences and Public Health, Multiple Sclerosis Centre, Binaghi Hospital, University of Cagliari, Cagliari, Italy.

R Capuano (R)

First Division of Neurology, University of Campania Luigi Vanvitelli, Piazza Miraglia, 2, 80138, Naples, Italy.

F Trojsi (F)

First Division of Neurology, University of Campania Luigi Vanvitelli, Piazza Miraglia, 2, 80138, Naples, Italy.

L Rosa (L)

Department of Neurosciences, Reproductive Sciences and Odontostomatology, University Federico II, Naples, Italy.

M Clerico (M)

Clinical and Biological Sciences Department, University of Torino, Turin, Italy.

A Laroni (A)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy.

V Brescia Morra (VB)

Department of Neurosciences, Reproductive Sciences and Odontostomatology, University Federico II, Naples, Italy.

G Tedeschi (G)

First Division of Neurology, University of Campania Luigi Vanvitelli, Piazza Miraglia, 2, 80138, Naples, Italy.
Neurological Institute for Diagnosis and Care "Hermitage Capodimonte", MRI Center SUN-FISM, Naples, Italy.

S Bonavita (S)

First Division of Neurology, University of Campania Luigi Vanvitelli, Piazza Miraglia, 2, 80138, Naples, Italy.
Neurological Institute for Diagnosis and Care "Hermitage Capodimonte", MRI Center SUN-FISM, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH